Dr. Beth Karlan is a leader in the field of research on early detection of ovarian cancer. She has received research grants from the Department of Defense, National Institutes of Health and the American Cancer Institute. Her research interests include the genetic definition and phenotypic determinants of human ovarian carcinomas, molecular biomarker discovery and inherited cancer susceptibility. This year, she is our winner of the Rosalind Franklin Excellence in Ovarian Cancer Research Award due to her commitment to innovative ovarian cancer research.
Related Topics
Harper’s Bazaar Honors the Legacy of Liz Tilberis, Our Organization’s First President
Harper’s Bazaar has published a powerful new piece by Chris Tilberis, who serves on OCRA’s Board of Directors, reflecting on his mother Liz Tilberis’ remarkable career as the former editor-in-chief … Continued
OCRA Champions Access and Equity in Ovarian Cancer and Gynecologic Cancer Awareness Month
As Ovarian and Gynecologic Cancer Awareness Month begins, Ovarian Cancer Research Alliance (OCRA) is proud to highlight a series of initiatives aimed at expanding access and promoting equity in ovarian and … Continued
The Overview: August 2024
Help OCRA Make an Impact for Ovarian Cancer and Gynecologic Cancer Awareness Month September is Ovarian Cancer Awareness Month and Gynecologic Cancer Awareness Month. As the largest non-profit in the … Continued